SavedAdd your journal

Journals / Abant Tıp Dergisi / 2025 / Cilt: 14 Sayı: 3

Recurrent Rhabdomyolysis after Kidney Transplant in Adult-Onset VLCAD Deficiency

Beyhan Güvercin(Karadeniz teknik üniversitesi)0000-0003-4157-4513
Büşra Korkmaz Baki(KARADENIZ TECHNICAL UNIVERSITY)0009-0004-2414-505X
Pages
230–233
Publication Date
2025-12-30
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We planned to discuss the case with the literature in order to emphasize that metabolic myopathies should also be evaluated in the etiology of patients who develop acute renal failure presenting with recurrent non-traumatic exercise-associated rhabdomyolysis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency is a hereditary disorder of mitochondrial long-chain fatty acid oxidation.
📊
Key Findings & Data:A 29-year-old male patient with hypertension, arrhythmia, and preemptive renal transplantation history was admitted to our clinic with complaints of recurrent hematuria attacks, body pain, and dizziness.
💡
Conclusion & Impact:We planned to discuss the case with the literature in order to emphasize that metabolic myopathies should also be evaluated in the etiology of patients who develop acute renal failure presenting with recurrent non-traumatic exercise-associated rhabdomyolysis.
🔬Design:Olgu Sunumu
📍Scope:Comprehensive Sample
⚙️Variables:Rhabdomyolysis · Very Long-Chain Acyl-CoA Dehydrogenase · Kidney Transplant

Abstract

Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency is a hereditary disorder of mitochondrial long-chain fatty acid oxidation. It is a syndrome characterized by rhabdomyolysis, muscle necrosis, and release of intracellular muscle components into the circulation. A 29-year-old male patient with hypertension, arrhythmia, and preemptive renal transplantation history was admitted to our clinic with complaints of recurrent hematuria attacks, body pain, and dizziness. No erythrocytes were observed in the microscopic field of urine sediment. In genetic analysis, a homozygous mutation was detected in the ACADVL gene in the NM_000018.4 C.1500_1502del CCT p. L502del variation, and VLCAD deficiency was diagnosed. We planned to discuss the case with the literature in order to emphasize that metabolic myopathies should also be evaluated in the etiology of patients who develop acute renal failure presenting with recurrent non-traumatic exercise-associated rhabdomyolysis.

🔖

Cite This Article

Güvercin, B., Baki, B. K. (2025). Recurrent Rhabdomyolysis after Kidney Transplant in Adult-Onset VLCAD Deficiency. Abant Tıp Dergisi, Cilt: 14 Sayı: 3, 230–233. https://doi.org/10.47493/abantmedj.1705660

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Marsden D, Bedrosian CL, Vockley J. Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disorders. Genet Med. 2021;23(5):816–829.
  2. Giannoglou GD, Chatzizisis YS, Misirli G. The syndrome of rhabdomyolysis: pathophysiology and diagnosis. Eur J Intern Med. 2007;18(2):90–100.
  3. Bhai S. Rhabdomyolysis: clinical manifestations and diagnosis. In: UpToDate [Internet]. Waltham, MA: UpToDate Inc.; 2025 Feb. Available from: https://www.uptodate.com/contents/rhabdomyolysis-clinical-manifestations-and-diagnosis
  4. Melli G, Chaudhry V, Cornblath DR. Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine (Baltimore). 2005;84(6):377–385.
  5. Fatehi F, Okhovat AA, Nilipour Y, Mroczek M, Straub V, Töpf A, et al. Adult-onset very-long-chain acyl-CoA dehydrogenase deficiency (VLCADD). Eur J Neurol. 2020;27(11):2257–2266.
  6. Andresen BS, Olpin S, Poorthuis BJ, Scholte HR, Vianey-Saban C, Wanders R, et al. Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency. Am J Hum Genet. 1999;64(2):479–494.
  7. Ahmed A, de Buitleir C, Elsheik N, Sweeney M. Very long-chain acyl-CoA dehydrogenase deficiency presenting as rhabdomyolysis. Ir Med J. 2022;115(3):565.
  8. Scalco RS, Gardiner AR, Pitceathly RD, Zanoteli E, Becker J, Holton JL, et al. Rhabdomyolysis: a genetic perspective. Orphanet J Rare Dis. 2015;10:51.
  9. Lucia A, Martinuzzi A, Nogales-Gadea G, Quinlivan R, Reason S; International Association for Muscle Glycogen Storage Disease study group. Clinical practice guidelines for glycogen storage disease V and VII (McArdle disease and Tarui disease) from an international study group. Neuromuscul Disord. 2021;31(12):1296–1310.
  10. Vockley J. Long-chain fatty acid oxidation disorders and current management strategies. Am J Manag Care. 2020;26(7 Suppl):S147–S154.